幹細胞治療の世界市場規模は、2023年に3億8,670万ドルと推定され、2024年から2030年にかけて24.15%のCAGRで成長すると予想されます。市場成長の主な推進要因の1つは、慢性疾患やがんや心血管疾患などの変性疾患の発生率の増加であり、新しい治療選択肢の探求につながっています。幹細胞治療は、損傷した組織や臓器を再生する可能性を秘めており、これらの衰弱性疾患に苦しむ患者に希望を与えています。
目次
Table of Contents
Chapter 1. Methodology and Scope
1.1. Market Segmentation and Scope
1.2. Market Definitions
1.2.1. Therapy Type
1.2.2. Therapeutic Application
1.3. Information analysis
1.4. Market formulation & data visualization
1.5. Data validation & publishing
1.6. Information Procurement
1.6.1. Primary Research
1.7. Information or Data Analysis
1.8. Market Formulation & Validation
1.9. Market Model
1.10. Objectives
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Snapshot
2.3. Competitive Landscape Snapshot
Chapter 3. Market Variables, Trends, & Scope
3.1. Market Lineage Outlook
3.1.1. Parent Market Outlook
3.1.2. Related/Ancillary Market Outlook
3.2. Market Dynamics
3.2.1. Market Driver Analysis
3.2.1.1. Growing research & development in stem cell therapy
3.2.1.2. Increasing prevalence of chronic diseases
3.2.1.3. Technological advancements
3.2.2. Market Restraint Analysis
3.2.2.1. High cost of stem cell therapy
3.3. Industry Analysis Tools
3.3.1. Porter's Five Forces Analysis
3.3.2. PESTEL Analysis
3.3.3. COVID-19 Impact Analysis
Chapter 4. Stem Cell Therapy Market: Therapy Type Business Analysis
4.1. Segment Dashboard
4.2. Global Stem Cell Therapy Market Therapy Type Movement Analysis
4.3. Global Stem Cell Therapy Market Size & Trend Analysis, by Therapy Type, 2018 to 2030 (USD Million)
4.4. Allogeneic Stem Cell Therapies
4.4.1. Global Allogeneic Stem Cell Therapies Market Estimates and Forecasts, 2018 - 2030 (USD Million)
4.4.2. Hematopoietic Stem Cell Therapies
4.4.2.1. Global Hematopoietic Stem Cell Therapies Market Estimates and Forecasts, 2018 - 2030 (USD Million)
4.4.3. Mesenchymal Stem Cell Therapies
4.4.3.1. Global Mesenchymal Stem Cell Therapies Market Estimates and Forecasts, 2018 - 2030 (USD Million)
4.5. Autologous Stem Cell Therapies, by Type
4.5.1. Global Autologous Stem Cell Therapies, by Type Market Estimates and Forecasts, 2018 - 2030 (USD Million)
4.5.2. BM, Blood, & Umbilical Cord-derived Stem Cells
4.5.2.1. Global BM, Blood, & Umbilical Cord-derived Stem Cells Market Estimates and Forecasts, 2018 - 2030 (USD Million)
4.5.3. Adipose-Derived Cells
4.5.3.1. Global Adipose-Derived Cells Market Estimates and Forecasts, 2018 - 2030 (USD Million)
4.5.4. Others
4.5.4.1. Global Others Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 5. Stem Cell Therapy Market: Therapeutic Application Business Analysis
5.1. Segment Dashboard
5.2. Global Stem Cell Therapy Market Therapeutic Application, Movement Analysis
5.3. Global Stem Cell Therapy Market Size & Trend Analysis, by Therapeutic Application, 2018 to 2030 (USD Million)
5.4. Oncology
5.4.1. Global Oncology Market Estimates and Forecasts, 2018 - 2030 (USD Million)
5.5. Cardiovascular Disease (CVD)
5.5.1. Global Cardiovascular Disease (CVD) Market Estimates and Forecasts, 2018 - 2030 (USD Million)
5.6. Musculoskeletal Disorders
5.6.1. Global Musculoskeletal Disorders Market Estimates and Forecasts, 2018 - 2030 (USD Million)
5.7. Others
5.7.1. Global Others Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 6. Stem Cell Therapy Market: Regional Estimates & Trend Analysis by Therapy Type, and Therapeutic pplication
6.1. Regional Dashboard
6.2. Market Size & Forecasts and Trend Analysis, 2018 to 2030
6.3. North America
6.3.1. North America Stem Cell Therapy Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.3.2. U.S.
6.3.2.1. Key Country Dynamics
6.3.2.2. Competitive Scenario
6.3.2.3. Regulatory Framework
6.3.2.4. U.S. Stem Cell Therapy Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.3.3. Canada
6.3.3.1. Key Country Dynamics
6.3.3.2. Competitive Scenario
6.3.3.3. Regulatory Framework
6.3.3.4. Canada Stem Cell Therapy Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.4. Europe
6.4.1. Europe Stem Cell Therapy Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.4.2. UK
6.4.2.1. Key Country Dynamics
6.4.2.2. Competitive Scenario
6.4.2.3. Regulatory Framework
6.4.2.4. UK Stem Cell Therapy Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.4.3. Germany
6.4.3.1. Key Country Dynamics
6.4.3.2. Competitive Scenario
6.4.3.3. Regulatory Framework
6.4.3.4. Germany Stem Cell Therapy Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.4.4. Switzerland
6.4.4.1. Key Country Dynamics
6.4.4.2. Competitive Scenario
6.4.4.3. Regulatory Framework
6.4.4.4. Switzerland Stem Cell Therapy Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.5. Asia Pacific
6.5.1. Asia Pacific Stem Cell Therapy Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.5.2. Japan
6.5.2.1. Key Country Dynamics
6.5.2.2. Competitive Scenario
6.5.2.3. Regulatory Framework
6.5.2.4. Japan Stem Cell Therapy Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.5.3. China
6.5.3.1. Key Country Dynamics
6.5.3.2. Competitive Scenario
6.5.3.3. Regulatory Framework
6.5.3.4. China Stem Cell Therapy Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.5.4. India
6.5.4.1. Key Country Dynamics
6.5.4.2. Competitive Scenario
6.5.4.3. Regulatory Framework
6.5.4.4. India Stem Cell Therapy Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.5.5. South Korea
6.5.5.1. Key Country Dynamics
6.5.5.2. Competitive Scenario
6.5.5.3. Regulatory Framework
6.5.5.4. South Korea Stem Cell Therapy Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.6. Rest of World
6.6.1. Rest of World Stem Cell Therapy Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 7. Competitive Landscape
7.1. Participant Categorization
7.2. Strategy Mapping
7.3. Company Market Position Analysis, 2023
7.4. Participant’s Overview
7.4.1. Bluebird Bio, Inc.
7.4.1.1. Overview
7.4.1.2. Financial Performance
7.4.1.3. Product Benchmarking
7.4.1.4. Strategic Initiatives
7.4.2. NIPRO
7.4.2.1. Overview
7.4.2.2. Financial Performance
7.4.2.3. Product Benchmarking
7.4.2.4. Strategic Initiatives
7.4.3. Orchard Therapeutics plc
7.4.3.1. Overview
7.4.3.2. Financial Performance
7.4.3.3. Product Benchmarking
7.4.3.4. Strategic Initiatives
7.4.4. Pharmicell Co., Ltd.
7.4.4.1. Overview
7.4.4.2. Financial Performance
7.4.4.3. Product Benchmarking
7.4.4.4. Strategic Initiatives
7.4.5. CorestemChemon Inc.
7.4.5.1. Overview
7.4.5.2. Financial Performance
7.4.5.3. Product Benchmarking
7.4.5.4. Strategic Initiatives
7.4.6. ANTEROGEN.CO.,LTD.
7.4.6.1. Overview
7.4.6.2. Financial Performance
7.4.6.3. Product Benchmarking
7.4.6.4. Strategic Initiatives
7.4.7. Holostem S.r.l.
7.4.7.1. Overview
7.4.7.2. Financial Performance
7.4.7.3. Product Benchmarking
7.4.7.4. Strategic Initiatives
7.4.8. Vertex Pharmaceuticals, Inc.
7.4.8.1. Overview
7.4.8.2. Financial Performance
7.4.8.3. Product Benchmarking
7.4.8.4. Strategic Initiatives
7.4.9. Cleveland Cord Blood Center
7.4.9.1. Overview
7.4.9.2. Financial Performance
7.4.9.3. Product Benchmarking
7.4.9.4. Strategic Initiatives
7.4.10. Gamida Cell Ltd.
7.4.10.1. Overview
7.4.10.2. Financial Performance
7.4.10.3. Product Benchmarking
7.4.10.4. Strategic Initiatives
List of Tables
Table 1 List of secondary sources
Table 2 List of abbreviations
Table 3 Global stem cell therapy market, by therapy type, 2018 - 2030 (USD Million)
Table 4 Global stem cell therapy market, by application, 2018 - 2030 (USD Million)
Table 5 Global stem cell therapy market, by region, 2018 - 2030 (USD Million)
Table 6 North America stem cell therapy market, by country, 2018 - 2030 (USD Million)
Table 7 North America stem cell therapy market, by therapy type, 2018 - 2030 (USD Million)
Table 8 North America stem cell therapy market, by therapeutical application, 2018 - 2030 (USD Million)
Table 9 U.S. stem cell therapy market, by therapy type, 2018 - 2030 (USD Million)
Table 10 U.S. stem cell therapy market, by therapeutical application, 2018 - 2030 (USD Million)
Table 11 U.S. stem cell therapy market, by end-use, 2018 - 2030 (USD Million)
Table 12 Canada stem cell therapy market, by therapy type, 2018 - 2030 (USD Million)
Table 13 Canada stem cell therapy market, by therapeutical application, 2018 - 2030 (USD Million)
Table 14 Europe stem cell therapy market, by country, 2018 - 2030 (USD Million)
Table 15 Europe stem cell therapy market, by therapy type, 2018 - 2030 (USD Million)
Table 16 Europe stem cell therapy market, by therapeutical application, 2018 - 2030 (USD Million)
Table 17 UK stem cell therapy market, by therapy type, 2018 - 2030 (USD Million)
Table 18 UK stem cell therapy market, by therapeutical application, 2018 - 2030 (USD Million)
Table 19 Germany stem cell therapy market, by therapy type, 2018 - 2030 (USD Million)
Table 20 Germany stem cell therapy market, by therapeutical application, 2018 - 2030 (USD Million)
Table 21 Switzerland stem cell therapy market, by therapy type, 2018 - 2030 (USD Million)
Table 22 Switzerland stem cell therapy market, by therapeutical application, 2018 - 2030 (USD Million)
Table 23 Asia Pacific stem cell therapy market, by country, 2018 - 2030 (USD Million)
Table 24 Asia Pacific stem cell therapy market, by therapy type, 2018 - 2030 (USD Million)
Table 25 Asia Pacific stem cell therapy market, by therapeutical application, 2018 - 2030 (USD Million)
Table 26 Japan stem cell therapy market, by therapy type, 2018 - 2030 (USD Million)
Table 27 Japan stem cell therapy market, by therapeutical application, 2018 - 2030 (USD Million)
Table 28 China stem cell therapy market, by therapy type, 2018 - 2030 (USD Million)
Table 29 China stem cell therapy market, by therapeutical application, 2018 - 2030 (USD Million)
Table 30 India stem cell therapy market, by therapy type, 2018 - 2030 (USD Million)
Table 31 India stem cell therapy market, by therapeutical application, 2018 - 2030 (USD Million)
Table 32 South Korea stem cell therapy market, by therapy type, 2018 - 2030 (USD Million)
Table 33 South Korea stem cell therapy market, by therapeutical application, 2018 - 2030 (USD Million)
Table 34 Rest of World stem cell therapy market, by therapy type, 2018 - 2030 (USD Million)
Table 35 Rest of World stem cell therapy market, by therapeutical application, 2018 - 2030 (USD Million)
Table 36 Participant's overview
Table 37 Financial performance
Table 38 Key companies undergoing expansions
Table 39 Key companies undergoing acquisitions
Table 40 Key companies undergoing collaborations
Table 41 Key companies launching new products
Table 42 Key companies undertaking other strategies
List of Figures
Fig. 1 Stem cell therapy market segmentation
Fig. 2 Market research process
Fig. 3 Data triangulation techniques
Fig. 4 Primary research pattern
Fig. 5 Market research approaches
Fig. 6 Market formulation & validation
Fig. 7 Market outlook
Fig. 8 Segment snapshot
Fig. 9 Competitive landscape snapshot
Fig. 10 Parent market outlook
Fig. 11 Stem cell therapy market driver analysis
Fig. 12 Stem cell therapy market restraint analysis
Fig. 13 Stem cell therapy market: Porter's analysis
Fig. 14 Stem cell therapy market: PESTEL analysis
Fig. 15 Stem cell therapy market: Therapy type outlook and key takeaways
Fig. 16 Stem cell therapy market: Therapy type market share analysis, 2023 - 2030
Fig. 17 Global stem cell therapy by allogeneic stem cell therapies market, 2018 - 2030 (USD Million)
Fig. 18 Global stem cell therapy by hematopoietic stem cell therapies market, 2018 - 2030 (USD Million)
Fig. 19 Global stem cell therapy by mesenchymal stem cell therapies market, 2018 - 2030 (USD Million)
Fig. 20 Global stem cell therapy by autologous stem cell therapies market, 2018 - 2030 (USD Million)
Fig. 21 Global stem cell therapy by BM, blood, & umbilical cord-derived stem cells market, 2018 - 2030 (USD Million)
Fig. 22 Global stem cell therapy by adipose derived cells market, 2018 - 2030 (USD Million)
Fig. 23 Global stem cell therapy by others market, 2018 - 2030 (USD Million)
Fig. 24 Stem cell therapy market: Therapeutical application outlook and key takeaways
Fig. 25 Stem cell therapy market: Therapeutical application market share analysis, 2023-2030
Fig. 26 Global stem cell therapy by oncology market, 2018 - 2030 (USD Million)
Fig. 27 Global stem cell therapy by cardiovascular disease (CVD) market, 2018 - 2030 (USD Million)
Fig. 28 Global stem cell therapy by musculoskeletal disorders market, 2018 - 2030 (USD Million)
Fig. 29 Global stem cell therapy by other market, 2018 - 2030 (USD Million)
Fig. 30 Regional marketplace: Key takeaways
Fig. 31 North America stem cell therapy market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 32 U.S. stem cell therapy market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 33 Canada stem cell therapy market, 2018 - 2030 (USD Million)
Fig. 34 Europe stem cell therapy market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 35 UK stem cell therapy market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 36 Germany stem cell therapy market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 37 Switzerland stem cell therapy market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 38 Asia-Pacific stem cell therapy market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 39 Japan stem cell therapy market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 40 China stem cell therapy market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 41 India stem cell therapy market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 42 South Korea stem cell therapy market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 43 Rest of World stem cell therapy market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 44 Key company categorization
Fig. 45 Company market positioning
Fig. 46 Market participant categorization
Fig. 47 Strategy framework
